Market
Additive Manufacturing Adhesives & Sealants Aerospace Agriculture Animal Nutrition & Health Automotive & Transportation Battery Building, Construction & Infrastructure Catalysts Chemical Industry Circular Economy Coatings, Paints & Printing Composites Consumer Goods & Lifestyle Electronics & Telecommunications Energy, Environment & Utilities Food & Beverage Green Hydrogen Home Care & Cleaning Industrial Manufacturing & Machinery Lubricants & Lubricant Additives Medical Devices Metals & Mining Oil & Gas, Petrochemicals Personal Care & Beauty Pharma & Health Care Plastics & Rubber Pulp, Paper & Packaging Textiles, Leather & Nonwovens
About Evonik
What drives us
We go beyond Innovation Purpose BVB Partnership History
Structure & Organization
Executive Board Supervisory Board Divisions Business Lines ESHQ Procurement Governance & Compliance Facts & Figures General Conditions of Sale and Delivery (GTC)
Business Lines Career Investor Relations
Alternativbild
SHARE
Halle/Westphalia
Menu
Products

With approximately 6,000 square meters of laboratory and office space, the Halle/Westphalia site is the heart of Evonik's biotechnology research.

It is home to operational research on biotechnological products and processes of Evonik's Health & Nutrition Business Unit. Research focuses on white biotechnology, i.e. the biotechnological manufacture of products for a wide range of industrial applications. The focus is on the development and optimization of fermentation processes.

Core competencies are molecular biology, bioinformatics, metabolic physiology, biochemistry, bioprocess technology, analysis of intracellular processes and cellular regulation as well as analytics for process control and characterization of fermentation products.

Around 100 employees in Halle/Westphalia develop and optimize the production processes for amino acids such as L-lysine, L-threonine and L-tryptophan, which are used as feed additives in animal nutrition, as well as for other fermentatively produced products. They also work on biotechnological processes for other Evonik business units.

The Halle/Westphalia site is operated by Baxter Oncology GmbH, the German subsidiary of the global pharmaceutical manufacturer Baxter International Inc.

The history of the Halle/Westphalia site goes back to 1919.

The commercial chemical company Henning and Kipper was founded in Bielefeld in 1919. Two years after the company was founded, manufacture of the pain reliever Quadronal began, which was the moment when ASTA-Werke AG came into being.

In the following decades, products such as Kamillosan, Treupel's Tablets, Honvan and the cytostatic drug Endoxan were developed.

In 1978, the former Degussa AG acquired two-thirds of the shares of ASTA-Werke AG. In 1987, ASTA-Werke AG—a wholly owned subsidiary of Degussa AG—was renamed ASTA Medica.

In 1999, the former Degussa AG divested itself of ASTA Medica, retaining only the research facility of what is today Evonik Industries AG.

The current research facility belongs to the Health & Nutrition Business Unit's Bioproducts Business Line.